Stay updated on Pembrolizumab for Recurrent Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page’s footer “Revision” has been updated from v3.5.0 to v3.5.3, indicating a platform/version update rather than a change to the study record itself.
    Difference
    0.1%
    Check dated 2026-04-25T18:45:06.000Z thumbnail image
  2. Check
    18 days ago
    No Change Detected
  3. Check
    39 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T01:04:20.000Z thumbnail image
  4. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; no visible changes to the study content.
    Difference
    0.1%
    Check dated 2026-03-06T18:29:33.000Z thumbnail image
  5. Check
    75 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.1 to v3.4.2; no changes to core study information or page layout are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:27:50.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and v3.4.0 was removed from the page.
    Difference
    0.1%
    Check dated 2026-02-05T17:12:16.000Z thumbnail image
  7. Check
    104 days ago
    Change Detected
    Summary
    A new Revision: v3.3.4 is added and the previous Revision: v3.3.3 is removed.
    Difference
    0.1%
    Check dated 2026-01-15T04:48:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Recurrent Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page.